glp 1 nasal spray The future of obesity treatment: Iconovo develops intranasal semaglutide Researchers are investigating a nasal‑spray

This review summarizes the discovery of GLP-1 and the development of GLP-1RAs, with a particular focus on their central mechanisms of action

How dual-hormone signaling supports appetite regulation

Early case studies saw poor wound healing and keloid formation in patients who had concurrently or recently taken isotretinoin and received NAL or ablative laser therapy, leading to the AAD recommendation to delay cutaneous laser treatments until 6 to 12 months after discontinuing isotretinoin

Abdominal fat and sleep apnea: the chicken or the egg

As off-label use of GLP-1 agonists continues to rise, particularly for weight loss in otherwise healthy individuals, the authors cite the need for additional guidelines and research